Where the Myeloma Reside? Part II

3 Black Docs

March is Multiple Meyeloma Awareness Month. In this episode, The Docs go over the treatment and diagnosis of multiple myeloma, as well as a few resource organizations and clinical trials you can reach out to today.

Listen to Part I for signs and symptoms of multiple myeloma.

Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Healthy plasma cells help you fight infections by making antibodies that recognize and attack germs. In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can cause complications.

Thanks to the many technological advances made in medicine, multiple myeloma is now mostly considered a chronic disease instead of a mortal illness if treated early.

If you or a loved one have been diagnosed with multiple myeloma, you should ask your doctor these 5 questions:

1. What stage of cancer do I have?
2. What treatments are you recommending?
3. Are there any clinical trials available?
4. Am I transplant eligible?
5. What are the financial implications of treatment?

Resources:

- The International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma.

- The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world focused on accelerating the cure for multiple myeloma.

-The Promise Study is testing qualifying adults with higher risks for multiple myeloma to be tested for early warning signs. See if you qualify for a free screening by clicking on the link.

--

New Episodes every Tuesday, available wherever you get your podcasts!

Rate and Subscribe! Also, join us for our live streams on Facebook and Youtube!

Sign Up for our newsletter here or at 3BlackDocs.com

A special thanks to our sponsor, Oncopeptides. Oncopeptides is a rapidly growing biotech company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is science driven and committed to bringing innovation to patients with an unmet medical need and improving patient lives. Oncopeptides is committed to the diversity of Multiple Myeloma patients and doing their part to eradicate health disparities in African American patients.

Learn more about Oncopeptides at https://www.oncopeptides.com/en

Join the Conversation! Follow us on social media!

3 Black Docs

facebook.com/3blackdocs
twitter.com/3blackdocs
instagram.com/3blackdocs
YouTube.com/3blackdocs

Dr. Karen Winkfield

facebook.com/drwinkfield
twitter.com/drwinkfield
instagram.com/drwinkfield

Dr. Zanetta Lamar

facebook.com/drzanetta
instagram.com/drzanetta